Participants 339 394 6
patients with intermediate-stage Hodgkin's disease (HD)
Participants 418 518 6
HD patients in stage I to IIIA with a large mediastinal mass, E stage, or massive spleen involvement
Participants 802 844 7
146 patients who responded to chemotherapy
Participants 988 1085 5
111 patients who fulfilled the same inclusion criteria in the subsequent trial HD5 (1988 to 1993)
Participants 1786 1848 3
modern polychemotherapy in patients with intermediate-stage HD
